|
The Case for Homeopathy i. Considerable potential for cost-saving In 1985, the superintendent of the Johannesburg General Hospital, the academic flag-ship of the University of the Witwatersrand’s medical school, told the incoming group of interns that the ‘golden age’ of unlimited spending on technological medicine had passed. The difficult choices politicians have to make regarding allocation of scarce resources affects medical decision-making at every level. Profit-driven private health insurance providers also seek ways to constrain medical spending. Against this background, it is necessary to document the financial implications of integrating the use of homeopathy in doctor’s daily practices. Considerable potential for cost-saving Dr. A. Jain M.B.B.S., M.D.(O+G), M.F.Hom. compared cost of medication in 100 of his patients, treated homeopathically, versus cost of pharmaceuticals which would otherwise have been prescribed for these patients48. He saved £60-40p. per homeopathically-treated patient and 92 of the patients improved according to the Glasgow Homoepathic Hospital Outcome Measure, without any demonstrable side effects. This study is a concise statement by a doctor that, in his hands, homeopathy is effective, safe and cost-effective. Many patients still try pharmaceutical treatment before resorting to homeopathy. A 1998 study on the use of homeopathy in Norway showed that almost half the patients had used pharmaceuticals prescribed by their medical doctor in the previous month for the same complaint 53. If doctors are trained in the use of homeopathy, they can decide when it is appropriate to use which modality of treatment, offering great potential for cost-savings. Savings demonstrated by U.K. homeopathic hospitals:
50% savings on outlays for doctors practicing
homeopathy compared to other G.P.’s, in France: Children with diarrhoea get better faster,
at less cost to the health system, when treated with homeopathy South African perspective Expenditure on pharmaceuticals in the private health insurance market in South Africa has grown from around 27% in 1988, to over 33% in 2002, of the overall ‘spend’ on non-administrative health-utilisable items. Contrast this to a decrease in expenditure on general practitioners services from around 21% in 1988 to 8% in 2002. A South African reality is that many peripheral clinics, particularly in rural areas, have no pharmaceuticals, for many reasons. This provides a fine opportunity for homeopathy to fill the gap, particularly as the expiry date of homeopathic medicines is much longer than that of pharmaceuticals, when suitably stored. Conclusion References 11. Jacobs, J. et al. Treatment of acute childhood diarrhea with homeopathic medicine: a randomized clinical trial in Nicaragua. Pediatrics 1998 93(5):719-725. 25. Royal London Homoeopathic Hospital. Audit Report 1994/95. London: RLHH. 27. International Data Collection Centres for Integrative Medicine. A review of inpatient care integrating complementary and orthodox medicine at Glasgow Homoeopathic Hospital. Interim inpatient report, 1998 33. Sharples F, van Haselen R.. Patients' perspectives on using a complementary medicine approach to their health. A survey at the Royal London Homoeopathic Hospital NHS Trust. London: 1998. 48. Jain A. Does homeopathy reduce the cost of conventional drug prescribing? A study of comparative prescribing costs in General Practice Homeopathy 2003 92:71-76 52. Jacobs J. et al Patient characteristics and practice patterns of physicians using homeopathy Arch Fam Med 1998 7(6):537-40 53. Steinsbekk A., Fonnebo V. Users of homeopaths in Norway in 1998, compared to previous users and GP patients Homeopathy 2003 92(1): 3-10 54. Chaufferin G. Improving the evaluation of homeopathy: economic considerations and impact on health Br Homeopath J 2000 89 Suppl 1: S27-30 |
Quick Links ::
Summary
|